How many institutions own MRM stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own MRM shares is 7, representing 1.43% of the company's common stock.

Who are the major shareholders selling MEDIROM Healthcare Technologies Inc. stock?

MARINER, LLC, in the last quarter, reduced its stake in MRM by -100% restricting it's holding to 0 shares of worth nearly -. CITADEL ADVISORS LLC also lessened -100% of the MRM shares from its portfolio, reducing its holding to 0 shares of worth -. UBS GROUP AG also shunned MRM shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying MRM stock?

As per its latest 13F filing, TOWER RESEARCH CAPITAL LLC (TRC) increased its stake in MRM by 30,600% in the last quarter. The institutional holder raised its holding to 3.38 thousand shares having worth more than $7.16K. GAMMA INVESTING LLC also added 4,336.54% more shares of MRM to its portfolio, raising its holding to 4.61 thousand shares of worth $9.78K. RHUMBLINE ADVISERS also increased its MRM shares holding by 18.82% which brought its holding to 1.31 thousand shares worth $2.77K.

MRM's major insiders: who are they?

The insider with the most stakes in MRM is COHEN EDWARD H , director at the company. Additionally, MRM stock is highly held by N/A N/A and N/A N/A among others.

Did an insider recently sell MRM stock?

Company executives, directors, and other insiders own 26.42% percent of MEDIROM Healthcare Technologies Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which MRM insiders have sold stock, totaling 0 shares. Insiders that have sold shares include COHEN EDWARD H.

Which insider recently purchased MRM stock?

There have been 0 transaction(s) during the past 6-months in which MEDIROM Healthcare Technologies Inc. insiders have bought stock, totalling 0 shares

How much of MRM does insiders own?

Around 0 MEDIROM Healthcare Technologies Inc. shares are held by insiders, which represents about 26.42% of MRM stock.

Who is the insider with the largest stake?

MRM director, COHEN EDWARD H holds the largest portfolio of the company's shares. MRM shares owned by COHEN total nearly 18.5 thousand.

Which institution holds the most shares in MRM?

MARINER, LLC is the largest institutional owner in MRM which holds 0 shares worth - or 0% of the total MRM shares outstanding followed by TOWER RESEARCH CAPITAL LLC (TRC) with ownership of 3.38 thousand shares representing 0.07% of the MRM ownership. GAMMA INVESTING LLC is the third largest stakeholder with 4.61 thousand shares or 0.09% of the ownership worth more than $9.78K.

Is MEDIROM Healthcare Technologies Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the MRM is concerned, it is a stock which is not optionable.

Is there a short position on MRM's shares?

Number of MRM shares short is 3.84K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding MRM shares are there?

As of today, 7.90M shares of MRM are outstanding.

Is there many float in MRM stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, MRM has 5.81M shares in float.

MRM short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for MRM is 0.17.

Stock Ideas

MRM Stock Ownership Breakdown

NASDAQ : MRM

MEDIROM Healthcare Technologies

$2.16

0.03+1.41%

Open: 2:25 PM

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares0.05

Short Percent Of Float0.06

Shares Outstanding7.90M

Shares Float5.81M

Shares Short3.84K

Short Ratio0.17

0.06%

Short % of Float

0.05%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

26.42% Percentage of Shares held by All Insiders

1.43% Percentage of Shares held by All Institutions

1.94% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 1.43% of MRM shares are held by financial institutions. MARINER, LLC is the top corporate investor, holding 0 shares valued at -. A 0% stake in MEDIROM Healthcare Technologies Inc. is owned by the company. TOWER RESEARCH CAPITAL LLC (TRC) owns 3.38K shares valued at $7.16K, which translates its holding of 0.07% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Sep 30, 2025	MARINER, LLC	0%	0	-	-19K	-100.00%
Sep 30, 2025	TOWER RESEARCH CAPITAL LLC (TRC)	0.07%	3.38K	7.16K	3.37K	+30,600.00%
Sep 30, 2025	GAMMA INVESTING LLC	0.09%	4.61K	9.78K	4.51K	+4,336.54%
Sep 30, 2025	CITADEL ADVISORS LLC	0%	0	-	-19.22K	-100.00%
Sep 30, 2025	RHUMBLINE ADVISERS	0.03%	1.31K	2.77K	207	+18.82%
Sep 30, 2025	UBS GROUP AG	0%	0	-	-33.28K	-100.00%
Sep 30, 2025	JANE STREET GROUP, LLC	3.04%	155.07K	328.75K	155.07K	+100.00%
Jun 30, 2025	TOWER RESEARCH CAPITAL LLC (TRC)	0%	11	16	11	+100.00%
Jun 30, 2025	UBS GROUP AG	0.65%	33.28K	47.26K	-65K	-66.14%
Jun 30, 2025	CITADEL ADVISORS LLC	0.38%	19.22K	26.9K	-48.21K	-71.50%
Jun 30, 2025	RHUMBLINE ADVISERS	0.02%	1.1K	1.54K	1.1K	+100.00%
Jun 30, 2025	MARINER, LLC	0.37%	19K	26.98K	19K	+100.00%
Jun 30, 2025	XTX TOPCO LTD	0%	0	-	-14.07K	-100.00%
Jun 30, 2025	GAMMA INVESTING LLC	0%	104	148	104	+100.00%
Mar 31, 2025	GAMMA INVESTING LLC	0%	0	-	-4.92K	-100.00%
Mar 31, 2025	UBS GROUP AG	1.92%	98.28K	36.17K	53.11K	+117.57%
Mar 31, 2025	CITADEL ADVISORS LLC	1.32%	67.43K	24.65K	67.43K	+100.00%
Mar 31, 2025	XTX TOPCO LTD	0.28%	14.07K	5.14K	508	+3.75%
Mar 31, 2025	HEIGHTS CAPITAL MANAGEMENT, INC	0%	0	-	-35.58K	-100.00%
Mar 31, 2025	WARBERG ASSET MANAGEMENT LLC	0%	0	-	-22.92K	-100.00%
Mar 31, 2024	BANK OF AMERICA CORP /DE/	0.01%	407	2.5K	382	+1,528.00%
Dec 31, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0%	0	-	-6	-100.00%
Dec 31, 2023	BANK OF AMERICA CORP /DE/	0%	25	143	-25	-50.00%
Sep 30, 2023	BANK OF AMERICA CORP /DE/	0%	50	289	50	+100.00%
Sep 30, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0%	6	34	6	+100.00%

Insiders

Among the MRM insiders holding of 26.42% of the stake in company, COHEN EDWARD H, director, holds the largest shares of 18.5K. , , is the second largest MRM insider with ownership of - shares. , , stands third with possession of - shares of that stake.

Insiders	Designation	Shares Held
COHEN EDWARD H	director	18.5K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Jun 11, 2009	COHEN EDWARD H	SALE	11.18	2.5K	27.95K	18.5K
Jun 23, 2004	COHEN EDWARD H	SALE	9.06	1.65K	14.95K	13K

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.